CN · Field Sheet
FIELD SHEET — YERBA MATE MFI-YERBAM-20261022-FS
Survey index / YERBA MATE

Yerba Mate.

Ilex paraguariensis
South American holly infusion; caffeine, metabolic and antioxidant literature.
SEALED MFI-YERBAM-20261022-FS · RELEASED 2026-10-22
SHEET FINGERPRINTMFI-YERBAM-20261022-FS
158INCLUDED
1,527EXCLUDED
27DUPLICATE
68NON-TRANSFERABLE
0OUT OF CUTOFF
Survey totalsScroll ↓
1,780records surveyed
158studies
29claims graded
81observations
5,908graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-5ca505ec613d492dGRADE VERY_LOW
yerba mate — cardiovascular
direction BENEFIT · dose 3 g · duration 15 days; 40 days
Grade basis — weakest-link ceilings
MODERATEdesign
MODERATEdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
6bound studies
Bound studies (4 shown of 6)
STU-2061827db4621871
UNSPECIFIED · HUMAN · 2026 · RoB NOT_ASSESSABLE
5 endpoints
STU-64cf29d5bd96e530
UNSPECIFIED · HUMAN · 2018 · RoB NOT_ASSESSABLE
1 endpoints
STU-82b9844145d8b14c
RCT · HUMAN · 2018 · RoB SOME_CONCERNS
3 endpoints
STU-87b3e4f443d3168f
COHORT · HUMAN · 2018 · RoB SOME_CONCERNS
6 endpoints
Quantitative observations
observation 15 days · failed extraction
observation 40 days · failed extraction
observation 3 g · validated
Opposition screen
SCREEN · 10 candidates considered · 3 bound as opposing
SYNTHESIS SYN-210405cf4eed11 — outcome QUALITATIVE_ONLY · BENEFIT ×6 · not_assessed_quantitatively · 6 members
PROVENANCE → epmc:42751122, epmc:29871836, epmc:29681860 · PKG 7875a52dcb51d7a4…
CLAIM · CLM-422da8bd9ca9f874GRADE VERY_LOW
yerba mate — cholesterol
direction BENEFIT · dose 3 g; 50 g · duration 12 weeks; 15 days; 40 days
Grade basis — weakest-link ceilings
MODERATEdesign
MODERATEdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
5bound studies
Bound studies (4 shown of 5)
STU-87b3e4f443d3168f
COHORT · HUMAN · 2018 · RoB SOME_CONCERNS
6 endpoints
STU-a4ad34107c2fca1e
RCT · HUMAN · 2009 · 40 days · RoB SOME_CONCERNS
2 endpoints
STU-d22081355cd73e81
RCT · HUMAN · 2016 · 15 days · RoB SOME_CONCERNS
3 endpoints
STU-ee6fd3dd80b61d42
UNSPECIFIED · HUMAN · 2015 · RoB NOT_ASSESSABLE
2 endpoints
Quantitative observations
observation 15 days · failed extraction
observation 40 days · failed extraction
observation 3 g · validated
Opposition screen
SCREEN · 9 candidates considered · 1 bound as opposing
SYNTHESIS SYN-26dcfd065d01f9 — outcome QUALITATIVE_ONLY · BENEFIT ×5 · not_assessed_quantitatively · 5 members
PROVENANCE → epmc:29694507, epmc:19694438, epmc:27223302 · PKG 7875a52dcb51d7a4…
Bounded preview — representative records only. The full release ships 29 claims and 81 observations.